Both HIV and antiretroviral therapy (ART, specifically the protease inhibitor and nucleoside reverse transcriptase inhibitor classes of agents) may modulate lipodystrophy via down-regulation of partial peroxisome proliferator-activated receptor-gamma (PPAR-γ) [8], [9]. Here, PPARG is linked to lipodystrophy.